0001022079-18-000151.txt : 20180705 0001022079-18-000151.hdr.sgml : 20180705 20180705163807 ACCESSION NUMBER: 0001022079-18-000151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180705 DATE AS OF CHANGE: 20180705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cunningham Everett CENTRAL INDEX KEY: 0001564777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 18940998 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_153082307077479.xml FORM 4 X0306 4 2018-07-02 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001564777 Cunningham Everett 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 SVP, Commercial Common Stock 2018-07-02 4 M 0 21294 52.165 A 67210 D Common Stock 2018-07-02 4 S 0 19798 109.642 D 47412 D Common Stock 2018-07-02 4 S 0 1496 110.122 D 45916 D Common Stock 2018-07-02 4 M 0 38928 66.51 A 84844 D Common Stock 2018-07-02 4 S 0 33345 109.596 D 51499 D Common Stock 2018-07-02 4 S 0 5583 110.066 D 45916 D Common Stock 2018-07-02 4 S 0 7066 109.627 D 38850 D Common Stock 2018-07-02 4 S 0 781 110.124 D 38261 D Common Stock 616 I 401(k) Non-Qualifed Stock Option (right to buy) 52.165 2018-07-02 4 M 0 21294 52.165 D 2024-02-13 Common Stock 21294.0 0 D Non-Qualifed Stock Option (right to buy) 66.51 2018-07-02 4 M 0 38928 66.51 D 2026-02-25 Common Stock 38928.0 19464 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. This transaction was executed in multiple trades at prices ranging from $109.07 to $110.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $110.07 to $110.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $109.00 to $110.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $110.00 to $110.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $109.08 to $110.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $110.08 to $110.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. William J. O'Shaughnessy, Jr., Attorney in Fact for Everett Cunningham 2018-07-05